BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27115538)

  • 1. Divergent transcription and epigenetic directionality of human promoters.
    Lacadie SA; Ibrahim MM; Gokhale SA; Ohler U
    FEBS J; 2016 Dec; 283(23):4214-4222. PubMed ID: 27115538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tight associations between transcription promoter type and epigenetic variation in histone positioning and modification.
    Nozaki T; Yachie N; Ogawa R; Kratz A; Saito R; Tomita M
    BMC Genomics; 2011 Aug; 12():416. PubMed ID: 21846408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide nucleosome specificity and function of chromatin remodellers in ES cells.
    de Dieuleveult M; Yen K; Hmitou I; Depaux A; Boussouar F; Bou Dargham D; Jounier S; Humbertclaude H; Ribierre F; Baulard C; Farrell NP; Park B; Keime C; Carrière L; Berlivet S; Gut M; Gut I; Werner M; Deleuze JF; Olaso R; Aude JC; Chantalat S; Pugh BF; Gérard M
    Nature; 2016 Feb; 530(7588):113-6. PubMed ID: 26814966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of promoter and enhancer transcription directionality in metazoans.
    Ibrahim MM; Karabacak A; Glahs A; Kolundzic E; Hirsekorn A; Carda A; Tursun B; Zinzen RP; Lacadie SA; Ohler U
    Nat Commun; 2018 Oct; 9(1):4472. PubMed ID: 30367057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleosome occupancy at transcription start sites in the human malaria parasite: a hard-wired evolution of virulence?
    Ponts N; Harris EY; Lonardi S; Le Roch KG
    Infect Genet Evol; 2011 Jun; 11(4):716-24. PubMed ID: 20708104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling transcriptional programs for cellular adaptation by chromatin regulation.
    Kim SC; Choi JK
    Mol Biosyst; 2011 May; 7(5):1713-9. PubMed ID: 21412562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin remodelling at promoters suppresses antisense transcription.
    Whitehouse I; Rando OJ; Delrow J; Tsukiyama T
    Nature; 2007 Dec; 450(7172):1031-5. PubMed ID: 18075583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis reveals increased histone modifications and a broad nucleosome-free region bound by histone acetylases in highly expressed genes in human CD4+ T cells.
    Liu H; Luo K; Wen H; Ma X; Xie J; Sun X
    Genomics; 2013 Feb; 101(2):113-9. PubMed ID: 23195408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylation of a specific promoter nucleosome accompanies activation of the epsilon-globin gene by beta-globin locus control region HS2.
    Gui CY; Dean A
    Mol Cell Biol; 2001 Feb; 21(4):1155-63. PubMed ID: 11158302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human genes with CpG island promoters have a distinct transcription-associated chromatin organization.
    Vavouri T; Lehner B
    Genome Biol; 2012 Nov; 13(11):R110. PubMed ID: 23186133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent transcription: a new feature of active promoters.
    Seila AC; Core LJ; Lis JT; Sharp PA
    Cell Cycle; 2009 Aug; 8(16):2557-64. PubMed ID: 19597342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peak-valley-peak pattern of histone modifications delineates active regulatory elements and their directionality.
    Pundhir S; Bagger FO; Lauridsen FB; Rapin N; Porse BT
    Nucleic Acids Res; 2016 May; 44(9):4037-51. PubMed ID: 27095194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitous human 'master' origins of replication are encoded in the DNA sequence via a local enrichment in nucleosome excluding energy barriers.
    Drillon G; Audit B; Argoul F; Arneodo A
    J Phys Condens Matter; 2015 Feb; 27(6):064102. PubMed ID: 25563930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-nucleosomal communication between histone modifications for nucleosome phasing.
    Chen W; Liu Y; Zhu S; Chen G; Han JJ
    PLoS Comput Biol; 2018 Sep; 14(9):e1006416. PubMed ID: 30188887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone modification: cause or cog?
    Henikoff S; Shilatifard A
    Trends Genet; 2011 Oct; 27(10):389-96. PubMed ID: 21764166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone H3 acetylated at lysine 9 in promoter is associated with low nucleosome density in the vicinity of transcription start site in human cell.
    Nishida H; Suzuki T; Kondo S; Miura H; Fujimura Y; Hayashizaki Y
    Chromosome Res; 2006; 14(2):203-11. PubMed ID: 16544193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RSC and GRFs confer promoter directionality by restricting divergent noncoding transcription.
    Wu AC; Vivori C; Patel H; Sideri T; Moretto F; van Werven FJ
    Life Sci Alliance; 2022 Sep; 5(12):. PubMed ID: 36114005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic malleability at core promoter initiates tobacco PR-1a expression post salicylic acid treatment.
    Lodhi N; Singh M; Srivastava R; Sawant SV; Tuli R
    Mol Biol Rep; 2023 Jan; 50(1):417-431. PubMed ID: 36335522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic transcriptional regulation of the growth arrest-specific gene 1 (Gas1) in hepatic cell proliferation at mononucleosomal resolution.
    Sacilotto N; Espert A; Castillo J; Franco L; López-Rodas G
    PLoS One; 2011; 6(8):e23318. PubMed ID: 21858068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.